Filing Details
- Accession Number:
- 0001103021-21-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-02 19:12:22
- Reporting Period:
- 2021-01-29
- Accepted Time:
- 2021-02-02 19:12:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1720772 | Theresa Mary Coelho | C/O Biodelivery Sciences Intl, Inc. 4131 Parklake Ave. Suite 225 Raleigh NC 27612 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-29 | 10,190 | $0.00 | 34,079 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-01 | 3,460 | $3.87 | 30,619 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2021-01-29 | 10,190 | $0.00 | 10,190 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,381 | 2023-01-29 | No | 4 | M | Direct |
Footnotes
- The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
- On February 1, 2021, the Reporting Person sold an aggregate of 3,460 shares of the Issuer's Common Stock at a weighted average price of $3.87 per share. The highest sale price for the Common Stock was $3.89 per share and the lowest sale price was $3.87 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 10,190 Restricted Stock Units ("RSUs") granted to the Reporting Person on January 29, 2020 under the Issuer's 2019 Stock Option Incentive Plan, as amended. The remainder of the RSUs under this grant will vest in equal portions on January 29, 2022 and January 29, 2023.
Billionaire Hedge Funds
